GROW Gerontological Research on Well-Being, Faculty of Medicine and Faculty of Human Sciences, University of Cologne, Cologne, Germany.
Health Care Managment, Central Krankenversicherung AG, Cologne, Germany.
Diabetes Technol Ther. 2019 Sep;21(9):514-521. doi: 10.1089/dia.2019.0056. Epub 2019 Jul 9.
Lifestyle interventions with personalized self-management programs have shown benefits for patients with type 2 diabetes mellitus (T2DM), a devastating highly prevalent disease worldwide. Despite advances in drug therapy and nonpharmacological strategies achieved in the past recent years, self-management programs to be implemented in everyday life are needed. The aim of the present prospective study was to evaluate the effects, in terms of glycated hemoglobin (HbA) values and self-management behavior, of a telemedicine-assisted self-management program offered to T2DM patients by a large private health insurance company. Participants with T2DM included 60 adults in the intervention group ( = 59.4 years) and 55 adults in the control group ( = 58.4 years). In the beginning of the study, the intervention group was provided with a tablet computer, a glucometer, and a step counter. Additionally, they received an individual need-based telephone coaching to address and improve motivation and diabetes self-management in daily life. The control group received care as usual and were not offered additional treatment. The study examined the results of a diabetes lifestyle program after 3 months. The intervention resulted in significantly greater declines in HbA compared with the control group. In addition, tele-assisted participants showed significant improvements in Diabetes Self-Management scale score and body mass index compared with usual care participants. Patients with T2DM can benefit from telemedicine-assisted self-management programs, which may offer new options for treatment and prevention of disease progression. More follow-up and research is needed to assess feasibility and effectiveness on a larger scale.
生活方式干预结合个性化自我管理方案已被证明对 2 型糖尿病（T2DM）患者有益，这是一种在全球范围内具有破坏性且普遍存在的疾病。尽管近年来在药物治疗和非药物策略方面取得了进展，但仍需要在日常生活中实施自我管理方案。本前瞻性研究的目的是评估通过大型私人健康保险公司为 T2DM 患者提供的远程医疗辅助自我管理方案在糖化血红蛋白（HbA）值和自我管理行为方面的效果。研究纳入了 60 名干预组（ = 59.4 岁）和 55 名对照组（ = 58.4 岁）的 T2DM 成年患者。在研究开始时，干预组提供了平板电脑、血糖仪和计步器。此外，他们还接受了基于个人需求的电话咨询，以解决和改善日常生活中的动机和糖尿病自我管理。对照组接受常规护理，不提供额外的治疗。研究检查了 3 个月后糖尿病生活方式方案的结果。干预组的 HbA 显著下降，与对照组相比差异有统计学意义。此外，与常规护理组相比，远程辅助组在糖尿病自我管理量表评分和体重指数方面均有显著改善。T2DM 患者可以从远程医疗辅助自我管理方案中受益，这可能为治疗和预防疾病进展提供新的选择。需要进行更多的随访和研究，以评估更大规模的可行性和有效性。
